Home » Canopus BioPharma, Inc.’s StatC Drug Shows Superior Results for Treatment of Avian Flu and Other Influenzas
Canopus BioPharma, Inc.’s StatC Drug Shows Superior Results for Treatment of Avian Flu and Other Influenzas
Canopus BioPharma, Inc, a biotechnology company developing pharmaceutical products and assay methods for patients suffering from infectious disease, bio-terrorism, cancer, and addiction, announced today groundbreaking results in animal trials for its drug candidate StatC against Avian Flu, Spanish Flu and Hong Kong Flu strains.
BioSpace
Upcoming Events
-
04Apr
-
11Apr
-
14Apr
-
25Apr
-
14May